Assessment of copulative function and severity of lower urinary tract symptoms in patients with benign prostatic hyperplasia after transurethral enucleation

Abstract

AIM: was to conduct a comparative assessment of copulative function and the severity of lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH) who underwent laser and bipolar transurethral enucleation of the prostate and who treated conservatively.

MATERIALS AND METHODS: 143 BPH patients aged 50 to 80 years (mean age 65 years) with complaints of copulatory and urinary disorders were under observation. All patients were divided into two groups. The 1st (main) group included 102 patients who underwent surgical treatment: transurethral laser enucleation of the prostate (n = 55) and transurethral bipolar enucleation of the prostate (n = 47). Patients of the 2nd group (n = 41) received conservative treatment. Control examinations were performed before treatment, 4, 12 and 24 weeks after it.

RESULTS: All 102 patients of group 1, regardless of the type of surgery, noted retrograde ejaculation four weeks after surgery. In the majority of patients of the 1st group during these periods weakening of orgasm was noted, in a significant number – deterioration of erection and decreased libido were noted. Upon further observation, by the 12th week after the operation, restoration of all components of the copulatory function was noted, with the exception of ejaculation. By the 24th week of observation, only in 2 patients of the 1st group the normal mechanism of ejaculation was restored. Surgical treatment of patients in group 1, regardless of the method of surgery, led to a significant decrease in the severity of LUTS, an increase in the maximum urine flow rate, a decrease in the volume of the prostate gland and the amount of residual urine. There were no significant differences in the dynamics of these indicators depending on the method of transurethral enucleation. The patients of the 2nd group also had an improvement in clinical parameters, but it was much less pronounced than in the 1st group.

CONCLUSION: Laser and bipolar transurethral enucleation of the prostate are effective surgical techniques that significantly improve the outflow of urine from the bladder, reduce the severity of LUTS and improve the sexual function of patients. Surgery is well tolerated by patients. At the same time, almost all patients operated on by these methods develop retrograde ejaculation.

Keywords

benign prostatic hyperplasia / transurethral laser enucleation of the prostate / transurethral bipolar enucleation of the prostate / copulative dysfunction / lower urinary tract symptoms

References

[1] Ministerstvo zdravookhraneniya Rossiiskoi Federatsii. Dobrokachestvennaya giperplazii predstatel’noi zhelezy. Klinicheskie rekomendatsii Ministerstva zdravookhraneniya Rossiiskoi Federatsii. Moscow, 2020. (In Russ.) Available from: https: // cr.minzdrav.gov.ru/schema/6_1

[2] Министерство здравоохранения Российской Федерации. Доброкачественная гиперплазии предстательной железы. Клинические рекомендации Министерства здравоохранения Российской Федерации. Москва, 2020. Доступ по ссылке: https: // cr.minzdrav.gov.ru/schema/6_1

[3] Gravas S, Cornu NJ, Gacci M, et al. Management of Non-neurogenic Male LUTS. European Association of Urology Guidelines. Available from: http: // uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/

[4] Gravas S., Cornu N.J., Gacci M., et al. Management of Non-neurogenic Male LUTS. European Association of Urology Guidelines. Доступ по ссылке: http: // uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/

[5] Pushkar’ DYu, Rasner PI, Kharchilava RR. Lower urinary tract symptoms and benign prostatic hyperplasia. Urologiia. 2016;(2):4–19. (In Russ.) DOI: 10.18565/urol.2017.3-supplement.4-18

[6] Пушкарь Д.Ю., Раснер П.И., Харчилава Р.Р. Симптомы нижних мочевыводящих путей и доброкачественная гиперплазия предстательной железы // Урология. 2016. № 2 (Приложение). С. 4–19. DOI: 10.18565/urol.2017.3-supplement.4-18

[7] Tiktinskii OL, Kalinina SN, Mikhailichenko VV. Andrologiya. Moscow: MIA. 2010. 576 p. Moscow: MIA, 2010. 576 p. (In Russ.)

[8] Тиктинский О.Л., Калинина С.Н., Михайличенко В.В. Андрология. М.: МИА. 2010. 576 с.

[9] Alyaev YuG, Glybochko PV, Pushkar’ DYu (editors). Urologiya. Rossiiskie klinicheskie rekomendatsii. Moscow: GEOTAR-Media, 2018. 480 p. (In Russ.)

[10] Урология. Российские клинические рекомендации. Под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря. М.: ГЭОТАР-Медиа; 2018. 480 с.

[11] Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3): 474–479. DOI: 10.1016/s0022-5347(17)49698-4

[12] Berry S.J., Coffey D.S., Walsh P.C., Ewing L.L. The development of human benign prostatic hyperplasia with age // J Urol. 1984. Vol. 132. No. 3. P. 474–479. DOI: 10.1016/s0022-5347(17)49698-4

[13] Al-Shukri SKh, Tkachuk VN, Gorbachev AG, et al. Urodinamicheskie issledovaniya v diagnostike infravezikal’noi obstruktsii u muzhchin. Urologiya i nefrologiya. 1998;(6):27–29. (In Russ.)

[14] Аль-Шукри С.Х., Ткачук В.Н., Горбачев А.Г., и др. Уродинамические исследования в диагностике инфравезикальной обструкции у мужчин // Урология и нефрология. 1998. № 6. С. 27–29.

[15] Al-Shukri SKh, Kuzmin IV. Quality of life in patients with overactive bladder. Urologicheskie vedomosti. 2011;1(1):21–26. (In Russ.) DOI: 10.17816/uroved57653

[16] Аль-Шукри С.Х., Кузьмин И.В. Качество жизни больных с гиперактивностью мочевого пузыря // Урологические ведомости. 2011. Т. 1, № 1. С. 21–26. DOI: 10.17816/uroved57653

[17] Taylor BC, Wilt TJ, Fink HA, et al. Osteoporotic Fractures in Men (MrOS) Study Research Group. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68(4):804–809. DOI: 10.1016/j.urology.2006.04.019

[18] Taylor B.C., Wilt T.J., Fink H.A., et al. Osteoporotic Fractures in Men (MrOS) Study Research Group. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study // Urology. 2006. Vol. 68. No. 4. P. 804–809. DOI: 10.1016/j.urology.2006.04.019

[19] Korneyev IA, Alexeeva TA, Al-Shukri SKh, Pushkar DYu. Lower urinary tract symptoms in male population of the Russian Federation North-Western region: analysis of population study results. Urologicheskie vedomosti. 2016;6(1):5–9. (In Russ.) DOI: 10.17816/uroved615-9

[20] Корнеев И.А., Алексеева Т.А., Аль-Шукри С.Х., Пушкарь Д.Ю. Симптомы нижних мочевых путей у мужчин Северо-Западного региона Российской Федерации: анализ результатов популяционного исследования // Урологические ведомости. 2016. Т. 6, № 1. C. 5–9. DOI: 10.17816/uroved615-9

[21] Kupelian V, McVary KT, Kaplan SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol. 2013;189(1):107–116. DOI: 10.1016/j.juro.2012.11.026

[22] Kupelian V., McVary K.T., Kaplan S.A., et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey // J Urol. 2013. Vol. 189. No. 1. P. 107–116. DOI: 10.1016/j.juro.2012.11.026

[23] Kalinina SN, Burlaka OO, Aleksandrov MS, Vydryn PS. Diagnosis and treatment of lower urinary tract symptoms and erectile dysfunction in patients with benign prostate hyperplasia. Urologicheskie vedomosti. 2018;8(1):26–33. (In Russ.) DOI: 10.17816/uroved8126-33

[24] Калинина С.Н., Бурлака О.О., Александров М.С., Выдрин П.С. Диагностика и лечение симптомов нижних мочевых путей и эректильной дисфункции у больных доброкачественной гиперплазией предстательной железы // Урологические ведомости. 2018. Т. 8, № 1. C. 26–33. DOI: 10.17816/uroved8126-33

[25] Kuzmin IV, Ajub AKh, Slesarevskaya MN. Phosphodiesterase type 5 inhibitors in treatment of lower urinary tract dysfunctions. Urology reports (St. Petersburg). 2020;10(1):67–74. (In Russ.) DOI: 10.17816/uroved10167-74

[26] Кузьмин И.В., Аюб А.Х., Слесаревская М.Н. Ингибиторы фосфодиэстеразы 5-го типа в лечении дисфункций нижних мочевых путей // Урологические ведомости. 2020. Т. 10, № 1. C. 67–74. DOI: 10.17816/uroved10167-74

[27] Al-Shukri AS, Kostyukov SV. Possibilities of phytotherapy in patients with lower urinary tract symptoms due to benign prostate enlargement. Urology reports (St. Petersburg). 2020;10(4):317–323. (In Russ.) DOI: 10.17816/uroved48969

[28] Аль-Шукри А.С., Костюков С.В. Возможности фитотерапии в лечении пациентов с симптомами нижних мочевых путей вследствие доброкачественного увеличения предстательной железы // Урологические ведомости. 2020. Т. 10, № 4. C. 317–323. DOI: 10.17816/uroved48969

[29] Al-Shukri SKh, Gorbachev AG, Borovets SYu, et al. Prostatilen treatment of prostatic adenoma. Urologiia. 2006;(6):22–25. (In Russ.)

[30] Аль-Шукри С.X., Горбачев А.Г., Боровец С.Ю., и др. Лечение больных аденомой предстательной железы простатиленом // Урология. 2006. № 6. С. 22–25.

[31] Park T, Choi JY. Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis. World J Urol. 2014;32(4):1093–1105. DOI: 10.1007/s00345-014-1258-9

[32] Park T., Choi J.Y. Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis // World J Urol. 2014. Vol. 32. No. 4. P. 1093–1105. DOI: 10.1007/s00345-014-1258-9

[33] Peshekhonov KS, Shpilenia ES, Burlaka OO. Significance of the pharmacoeconomic approach in the choice of treatment of hyperplasia of the prostate. Urologicheskie vedomosti. 2019;9(4):59–72. (In Russ.) DOI: 10.17816/uroved9459-72

[34] Пешехонов К.С., Шпиленя Е.С., Бурлака О.О. Значимость фармакоэкономического подхода при выборе лечения гиперплазии предстательной железы // Урологические ведомости. 2019. Т. 9, № 4. C. 59–72. DOI: 10.17816/uroved9459-72

[35] Gandhi J, Weissbart SJ, Smith NL, et al. The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia. Transl Androl Urol. 2017;6(2):295–304. DOI: 10.21037/tau.2017.03.57

[36] Gandhi J., Weissbart S.J., Smith N.L., et al. The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia // Transl Androl Urol. 2017. Vol. 6. No. 2. P. 295–304. DOI: 10.21037/tau.2017.03.57

[37] Mustafaev AT, Kyzlasov PS, Dianov MP, et al. Surgical treatment of benign prostatic hyperplasia: the past and the present. Urologicheskie vedomosti. 2019;9(1):47–56. (In Russ.) DOI: 10.17816/uroved9147-56

[38] Мустафаев А.Т., Кызласов П.С., Дианов М.П., и др. Хирургическое лечение доброкачественной гиперплазии предстательной железы: прошлое и настоящее // Урологические ведомости. 2019. Т. 9, № 1. C. 47–56. DOI: 10.17816/uroved9147-56

[39] Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 2007;52(5):1456–1463. DOI: 10.1016/j.eururo.2007.04.053

[40] Ahyai S.A., Lehrich K., Kuntz R.M. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial // Eur Urol. 2007. Vol. 52. No. 5. P. 1456–1463. DOI: 10.1016/j.eururo.2007.04.053

[41] Sevryukov FA, Sorokin DA, Karpukhin IV, et al. Transurethral enucleation of prostate (TUEB) – new option in bipolar endoscopic surgery of BPH. Experimental & clinical urology. 2012;(2):34–36. (In Russ.)

[42] Севрюков Ф.А., Сорокин Д.А., Карпухин И.В., и др. Трансуретральная энуклеация предстательной железы (TUEB) — новый метод биполярной эндоскопической хирургии ДГПЖ // Экспериментальная и клиническая урология. 2012. № 2. С. 34–36.

[43] Martov AG, Ergakov DV, Turin DE, Andronov AS. Bipolar and laser endoscopic enucleation for large benign prostatic hyperplasia. Urologiia. 2020;(1):59–63. (In Russ.) DOI: 10.18565/urology.2020.1.59-63

[44] Мартов А.Г., Ергаков Д.В., Турин Д.Е., Андронов А.С. Биполярная и лазерная эндоскопическая энуклеация доброкачественной гиперплазии предстательной железы больших размеров // Урология. 2020. № 1. С. 59–63. DOI: 10.18565/urology.2020.1.59-63

[45] Robert G, Cornu JN, Fourmarier M, et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int. 2016;117(3):495–499. DOI: 10.1111/bju.13124

[46] Robert G., Cornu J.N., Fourmarier M., et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP) // BJU Int. 2016. Vol. 117. No. 3. P. 495–499. DOI: 10.1111/bju.13124

[47] Gilling PJ, Aho TF, Frampton CM, et al. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol. 2008;53(4):744–749. DOI: 10.1016/j.eururo.2007.04.052

[48] Gilling P.J., Aho T.F., Frampton C.M., et al. Holmium laser enucleation of the prostate: results at 6 years // Eur Urol. 2008. Vol. 53. No. 4. P. 744–749. DOI: 10.1016/j.eururo.2007.04.052

[49] Alyaev YuG, Vinarov AZ, Akhvlediani ND. Ehrektil’naya disfunktsiya posle transuretral’nykh operatsii po povodu giperplazii predstatel’noi zhelezy. Vrachebnoe soslovie. 2004;(7):37. (In Russ.)

[50] Аляев Ю.Г., Винаров А.З., Ахвледиани Н.Д. Эректильная дисфункция после трансуретральных операций по поводу гиперплазии предстательной железы // Врачебное сословие. 2004. № 7. С. 37.

[51] Efremov EA, Dorofeev SD. Ehrektil’naya disfunktsiya u patsientov, perenesshikh transuretral’nye ehndoskopicheskie operativnye vmeshatel’stva na predstatel’noi zheleze po povodu ee dobrokachestvennoi giperplazii. RMZH. 2004;(8):527. (In Russ.) [Cited 15.06.2021]. Available from: https: // www.rmj.ru/articles/urologiya/Erektilynaya_disfunkciya_u_pacientov_perenesshih_transuretralynye_endoskopicheskie_operativnye_vmeshatelystva_na_predstatelynoy_gheleze_po_povodu_ee_dobrokachestvennoy_giperplazii/

[52] Ефремов Е.А., Дорофеев С.Д. Эректильная дисфункция у пациентов, перенесших трансуретральные эндоскопические оперативные вмешательства на предстательной железе по поводу ее доброкачественной гиперплазии // РМЖ. 2004. № 8. С. 527. [дата обращения: 15.06.2021]. Доступ по ссылке: https: // www.rmj.ru/articles/urologiya/Erektilynaya_disfunkciya_u_pacientov_perenesshih_transuretralynye_endoskopicheskie_operativnye_vmeshatelystva_na_predstatelynoy_gheleze_po_povodu_ee_dobrokachestvennoy_giperplazii

[53] Placer J, Salvador C, Planas J, et al. Effects of holmium laser enucleation of the prostate on sexual function. J Endourol. 2015;29(3):332–339. DOI: 10.1089/end.2014.0502

[54] Placer J., Salvador C., Planas J., et al. Effects of holmium laser enucleation of the prostate on sexual function // J Endourol. 2015. Vol. 29. No. 3. P. 332–339. DOI: 10.1089/end.2014.0502

[55] Popov SV, Orlov IN, Grin YA, et al. State of copulative function in patients after the holmium laser enuсleation of benign prostatic hyperplasia. Urologicheskie vedomosti. 2019;9(2):17–22. (In Russ.) DOI: 10.17816/uroved9217-22

[56] Попов С.В., Орлов И.Н., Гринь Е.А., и др. Состояние копулятивной функции у больных после гольмиевой лазерной энуклеации доброкачественной гиперплазии предстательной железы // Урологические ведомости. 2019. Т. 9, № 2. C. 17–22. DOI: 10.17816/uroved9217-22

[57] Kyzlasov PS, Martov AG, Popov SV, et al. Erectile dysfunction after transurethral surgery for benign prostatic hyperplasia. Journal of VolgSMU. 2017;(3):10–15. (In Russ.) DOI: 10.19163/1994-9480-2017-3(63)-10-15

[58] Кызласов П.С., Мартов А.Г., Попов С.В., и др. Эректильная дисфункция после трансуретральной хирургии при доброкачественной гиперплазии предстательной железы // Вестник ВолгГМУ. 2017. № 3. С. 10–15. DOI: 10.19163/1994-9480-2017-3(63)-10-15

[59] Frieben RW, Lin HC, Hinh PP, et al. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl. 2010;12(4):500–508. DOI: 10.1038/aja.2010.33

[60] Frieben R.W., Lin H.C., Hinh P.P., et al. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review // Asian J Androl. 2010. Vol. 12. No. 4. P. 500–508. DOI: 10.1038/aja.2010.33

[61] Kim SH, Yang HK, Lee HE, et al. HoLEP does not affect the overall sexual function of BPH patients: a prospective study. Asian J Androl. 2014;16(6):873–877. DOI: 10.4103/1008-682X.132469.

[62] Kim S.H., Yang H.K., Lee H.E., et al. HoLEP does not affect the overall sexual function of BPH patients: a prospective study // Asian J Androl. 2014. Vol. 16. No. 6. P. 873–877. DOI: 10.4103/1008-682X.132469.

RIGHTS & PERMISSIONS

Eco-Vector